LeMaitre Vascular, which provides medical devices (i.e. catheters) to treat peripheral vascular disease, priced 5.5 million shares at $7. The company planned to offer 6 million shares at a range of $8-$10. Goldman Sachs, CIBC World Markets, Cowen & Company and Thomas Wesiel managed the deal. The stock is expected to begin trading Thursday morning on the NASDAQ under the ticker LMAT.
